• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

靶向慢性耐甲氧西林金黄色葡萄球菌感染的纳米工程抗生素制剂。

Nano-engineered Antibiotic Formulation That Targets Chronic MRSA Infection.

作者信息

Praseetha P K, Vijayakumar S, Gangadhar Lekshmi, Gopukumar S T, Vijayakumar S

机构信息

Department of Nanotechnology, Noorul Islam Centre for Higher Education, Kumaracoil, Tamilnadu, India.

Department of Botany, A.V.V.M Sri Pushpam College (Autonomous) Affiliated to Bharathidasan University, Poondi, Thanjavur, Tamil Nadu, India.

出版信息

Appl Biochem Biotechnol. 2025 May 27. doi: 10.1007/s12010-025-05282-5.

DOI:10.1007/s12010-025-05282-5
PMID:40423746
Abstract

The health of millions of people is seriously threatened by infectious diseases that spread rapidly within communities and can lead to outbreaks if not effectively controlled by medical personnel. This study examines the complex mechanisms of antibiotic resistance, specifically focusing on the emergence of methicillin-resistant Staphylococcus aureus (MRSA) and Extended-Spectrum Beta-Lactamase (ESBL)-producing bacteria in Indian healthcare settings. MRSA isolates exhibited complete resistance to ampicillin, ciprofloxacin, amoxicillin, and amoxicillin-clavulanic acid on Mueller-Hinton agar plates. Characterization results indicated an increased inhibition zone diameter and enhanced encapsulation integrity. UV-visible spectrophotometric analysis revealed that ciprofloxacin-loaded liposomes achieved an entrapment efficiency of 16.45% after 1 h, increasing to 76% after 24 h. Encapsulation of ciprofloxacin, amikacin, cloxacillin, and vancomycin within vesicles demonstrated improved antimicrobial efficacy against Escherichia coli, Staphylococcus aureus, Acinetobacter baumannii, Klebsiella pneumoniae, and MRSA. Moreover, liposome-encapsulated aminoglycosides exhibited promising potential against A. baumannii, particularly in localized infections where sustained drug concentrations at the infection site are essential. The results of this study suggest that liposomal antibiotics hold significant potential for treating severe infections both systemically and topically. They may enhance therapeutic effectiveness while minimizing adverse effects, offering a promising approach to combating antibiotic-resistant bacterial infections.

摘要

数百万人的健康受到传染病的严重威胁,这些传染病在社区内迅速传播,如果医务人员不能有效控制,可能导致疫情爆发。本研究考察了抗生素耐药性的复杂机制,特别关注印度医疗环境中耐甲氧西林金黄色葡萄球菌(MRSA)和产超广谱β-内酰胺酶(ESBL)细菌的出现。在穆勒-欣顿琼脂平板上,MRSA分离株对氨苄西林、环丙沙星、阿莫西林和阿莫西林-克拉维酸表现出完全耐药性。表征结果表明抑菌圈直径增加,包封完整性增强。紫外-可见分光光度分析显示,载有环丙沙星的脂质体在1小时后包封率为16.45%,24小时后增至76%。将环丙沙星、阿米卡星、氯唑西林和万古霉素包裹在囊泡中,对大肠杆菌、金黄色葡萄球菌、鲍曼不动杆菌、肺炎克雷伯菌和MRSA显示出更好的抗菌效果。此外,脂质体包裹的氨基糖苷类药物对鲍曼不动杆菌显示出有前景的潜力,特别是在局部感染中,在感染部位维持药物浓度至关重要。本研究结果表明,脂质体抗生素在全身和局部治疗严重感染方面具有巨大潜力。它们可能提高治疗效果,同时将副作用降至最低,为对抗耐药细菌感染提供了一种有前景的方法。

相似文献

1
Nano-engineered Antibiotic Formulation That Targets Chronic MRSA Infection.靶向慢性耐甲氧西林金黄色葡萄球菌感染的纳米工程抗生素制剂。
Appl Biochem Biotechnol. 2025 May 27. doi: 10.1007/s12010-025-05282-5.
2
Antibacterial and antibiofilm potentials of vancomycin-loaded niosomal drug delivery system against methicillin-resistant Staphylococcus aureus (MRSA) infections.载万古霉素的脂质体药物传递系统对耐甲氧西林金黄色葡萄球菌(MRSA)感染的抗菌和抗生物膜潜力。
BMC Biotechnol. 2024 Jul 8;24(1):47. doi: 10.1186/s12896-024-00874-1.
3
Bacteriophage infection drives loss of β-lactam resistance in methicillin-resistant .噬菌体感染导致耐甲氧西林菌丧失β-内酰胺抗性 。
Elife. 2025 Jul 10;13:RP102743. doi: 10.7554/eLife.102743.
4
Adaptive laboratory-evolved MRSA with PPEF manifests cross-susceptibility to oxacillin and hypersensitivity to ciprofloxacin.具有PPEF的适应性实验室进化型耐甲氧西林金黄色葡萄球菌对苯唑西林表现出交叉敏感性,对环丙沙星表现出超敏反应。
Microbiol Spectr. 2025 Aug 5;13(8):e0297424. doi: 10.1128/spectrum.02974-24. Epub 2025 Jul 15.
5
Antibiotic prophylaxis for the prevention of methicillin-resistant Staphylococcus aureus (MRSA) related complications in surgical patients.用于预防外科手术患者耐甲氧西林金黄色葡萄球菌(MRSA)相关并发症的抗生素预防措施。
Cochrane Database Syst Rev. 2013 Aug 19;2013(8):CD010268. doi: 10.1002/14651858.CD010268.pub2.
6
Respiratory tract antimicrobial peptides more effectively killed multiple methicillin-resistant and nontypeable isolates after disruption from biofilm residence.呼吸道抗菌肽在从生物膜驻留中破坏后,能更有效地杀死多种耐甲氧西林和不可分型的分离株。
Microbiol Spectr. 2025 Jun 18:e0306624. doi: 10.1128/spectrum.03066-24.
7
Investigating the Prevalence of Enterotoxin and Antibiotic Resistance in Methicillin-Resistant Staphylococcus aureus (MRSA) Isolated From Meat and Edible Viscera of Broiler Chickens.调查从肉鸡的肉和可食用内脏中分离出的耐甲氧西林金黄色葡萄球菌(MRSA)中肠毒素的流行情况和抗生素耐药性。
Vet Med Sci. 2025 Jul;11(4):e70413. doi: 10.1002/vms3.70413.
8
Tailoring moxifloxacin hydrochloride loaded oleic acid liposomes for the topical management of Methicillin-Resistant Staphylococcus aureus (MRSA)- Induced skin infection: In-vitro characterization and in-vivo assessment.定制负载盐酸莫西沙星的油酸脂质体用于耐甲氧西林金黄色葡萄球菌(MRSA)引起的皮肤感染的局部治疗:体外表征和体内评估。
Int J Pharm. 2025 Feb 10;670:125115. doi: 10.1016/j.ijpharm.2024.125115. Epub 2024 Dec 20.
9
Antibiotic therapy for the treatment of methicillin-resistant Staphylococcus aureus (MRSA) in non surgical wounds.用于治疗非手术伤口耐甲氧西林金黄色葡萄球菌(MRSA)感染的抗生素疗法。
Cochrane Database Syst Rev. 2013 Nov 18;2013(11):CD010427. doi: 10.1002/14651858.CD010427.pub2.
10
Interventions for the eradication of meticillin-resistant Staphylococcus aureus (MRSA) in people with cystic fibrosis.根除囊性纤维化患者体内耐甲氧西林金黄色葡萄球菌(MRSA)的干预措施。
Cochrane Database Syst Rev. 2018 Jul 21;7(7):CD009650. doi: 10.1002/14651858.CD009650.pub4.

本文引用的文献

1
Biofunctional lipid nanoparticles for precision treatment and prophylaxis of bacterial infections.用于精准治疗和预防细菌感染的生物功能脂质纳米颗粒。
Sci Adv. 2024 Apr 5;10(14):eadk9754. doi: 10.1126/sciadv.adk9754.
2
Resveratrol and Resveratrol-Loaded Galactosylated Liposomes: Anti-Adherence and Cell Wall Damage Effects on and MRSA.白藜芦醇和载白藜芦醇半乳糖化脂质体对 和 MRSA 的抗黏附及细胞壁损伤作用。
Biomolecules. 2023 Dec 14;13(12):1794. doi: 10.3390/biom13121794.
3
Community carriage of ESBL-producing and : a cross-sectional study of risk factors and comparative genomics of carriage and clinical isolates.
产 ESBL 菌和 :定植和临床分离株的危险因素和比较基因组学的横断面研究。
mSphere. 2023 Aug 24;8(4):e0002523. doi: 10.1128/msphere.00025-23. Epub 2023 Jun 12.
4
Nanoparticles for Antimicrobial Agents Delivery-An Up-to-Date Review.纳米颗粒用于抗菌药物传递——最新综述。
Int J Mol Sci. 2022 Nov 10;23(22):13862. doi: 10.3390/ijms232213862.
5
Updates on Responsive Drug Delivery Based on Liposome Vehicles for Cancer Treatment.基于脂质体载体的癌症治疗响应性药物递送研究进展
Pharmaceutics. 2022 Oct 15;14(10):2195. doi: 10.3390/pharmaceutics14102195.
6
Occurrence of antibiotics and bacterial resistance genes in wastewater: resistance mechanisms and antimicrobial resistance control approaches.污水中抗生素和细菌耐药基因的出现:耐药机制和抗菌耐药性控制方法。
World J Microbiol Biotechnol. 2022 Jul 4;38(9):152. doi: 10.1007/s11274-022-03334-0.
7
Nanostructured Antibiotics and Their Emerging Medicinal Applications: An Overview of Nanoantibiotics.纳米结构抗生素及其新兴医学应用:纳米抗生素概述
Antibiotics (Basel). 2022 May 25;11(6):708. doi: 10.3390/antibiotics11060708.
8
A Review of Liposomes as a Drug Delivery System: Current Status of Approved Products, Regulatory Environments, and Future Perspectives.脂质体作为药物传递系统的综述:已批准产品的现状、监管环境和未来展望。
Molecules. 2022 Feb 17;27(4):1372. doi: 10.3390/molecules27041372.
9
Liposomes for malaria management: the evolution from 1980 to 2020.脂质体用于疟疾管理:1980 年至 2020 年的发展历程。
Malar J. 2021 Jul 27;20(1):327. doi: 10.1186/s12936-021-03858-0.
10
Evolutionary Pathways and Trajectories in Antibiotic Resistance.抗生素耐药性的进化途径和轨迹。
Clin Microbiol Rev. 2021 Dec 15;34(4):e0005019. doi: 10.1128/CMR.00050-19. Epub 2021 Jun 30.